CareDx Inc (NASDAQ:CDNA) — Market Cap & Net Worth
Market Cap & Net Worth: CareDx Inc (CDNA)
CareDx Inc (NASDAQ:CDNA) has a market capitalization of $1.42 Billion ($1.42 Billion) as of August 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7298 globally and #2216 in its home market, demonstrating a 16.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CareDx Inc's stock price $43.71 by its total outstanding shares 51659481 (51.66 Million). See CareDx Inc capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
CareDx Inc Market Cap History: 2015 to 2026
CareDx Inc's market capitalization history from 2015 to 2026. Data shows growth from $330.62 Million to $2.26 Billion (22.35% CAGR).
Index Memberships
CareDx Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.06% | #211 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #817 of 3165 |
Weight: CareDx Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CareDx Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CareDx Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.56x
CareDx Inc's market cap is 2.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $139.48 Million | $40.63 Million | -$39.47 Million | 3.43x | N/A |
| 2017 | $379.18 Million | $48.32 Million | -$55.47 Million | 7.85x | N/A |
| 2018 | $1.30 Billion | $76.57 Million | -$46.76 Million | 16.96x | N/A |
| 2019 | $1.11 Billion | $127.07 Million | -$21.97 Million | 8.77x | N/A |
| 2020 | $3.74 Billion | $192.19 Million | -$18.71 Million | 19.47x | N/A |
| 2021 | $2.35 Billion | $296.40 Million | -$30.66 Million | 7.93x | N/A |
| 2022 | $589.43 Million | $321.79 Million | -$76.61 Million | 1.83x | N/A |
| 2023 | $619.91 Million | $280.32 Million | -$190.28 Million | 2.21x | N/A |
| 2024 | $1.11 Billion | $333.79 Million | $52.55 Million | 3.31x | 21.05x |
| 2025 | $973.26 Million | $379.81 Million | -$21.35 Million | 2.56x | N/A |
Competitor Companies of CDNA by Market Capitalization
Companies near CareDx Inc in the global market cap rankings as of August 1, 2026.
Key companies related to CareDx Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
CareDx Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, CareDx Inc's market cap moved from $330.62 Million to $ 2.26 Billion, with a yearly change of 22.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.26 Billion | +132.01% |
| 2025 | $973.26 Million | -12.00% |
| 2024 | $1.11 Billion | +78.42% |
| 2023 | $619.91 Million | +5.17% |
| 2022 | $589.43 Million | -74.91% |
| 2021 | $2.35 Billion | -37.23% |
| 2020 | $3.74 Billion | +235.88% |
| 2019 | $1.11 Billion | -14.20% |
| 2018 | $1.30 Billion | +242.51% |
| 2017 | $379.18 Million | +171.85% |
| 2016 | $139.48 Million | -57.81% |
| 2015 | $330.62 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of CareDx Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.42 Billion USD |
| MoneyControl | $1.42 Billion USD |
| MarketWatch | $1.42 Billion USD |
| marketcap.company | $1.42 Billion USD |
| Reuters | $1.42 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CareDx Inc
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart tr… Read more